By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pharmalink AB 

Karlavägen 18

Stockholm    SE-102 49  Sweden
Phone: 46-0-8-505-66-312 Fax: 46-0-8-611-3303



Company News
Pharmalink AB Raises SEK100m To Advance Nefecon Development As New Treatment For Kidney Disease 10/1/2015 6:11:56 AM
Pharmalink AB Phase II Trial Of Nefecon Halted Early 4/14/2015 6:15:40 AM
Pharmalink AB Acquires Novel Therapeutic Product Candidate For Treating Inflammation Associated With Osteoarthritis 3/18/2015 6:41:50 AM
Data From Clinical Study Of Pharmalink AB's Nefecon® To Be Presented At American Society Of Nephrology's Kidney Week 2014 11/3/2014 7:25:58 AM
Pharmalink AB Extends Patent Protection For Nefecon® Treatment For Renal Disease 10/27/2014 7:46:30 AM
Pharmalink AB Elects Bengt Julander As Chairman 10/14/2014 8:32:40 AM
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014 9:49:12 AM
Pharmalink AB Strengthens its Board Of Directors 7/7/2014 10:58:08 AM
Pharmalink AB Receives US Orphan Drug Designation for Busulipo™, its Novel Oncology Product for Bone Marrow Transplantation 10/29/2013 10:24:04 AM
Pharmalink AB Snags $15 Million to Undertake Pivotal Studies With Lead Programs in Cancer Therapy and Renal Disease 10/4/2013 6:54:58 AM